1-3 of 3
Hatice Satilmis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of Oxidative Phosphorylation and Glycolysis Reduces Viability in Multiple Myeloma By Affecting mTOR-Mediated Protein Synthesis

Inge Oudaert, Arne Van der Vreken, Gamze Ates, Sylvia Faict, Philip Vlummens, Hatice Satilmis, Rong Fan, Anke Maes, Elke De Bruyne, Kim De Veirman, Ann Massie, Karin Vanderkerken, Eline Menu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7078–7079.
https://doi.org/10.1182/blood-2022-167025
Published: 2022
Journal Articles

Pyrroline-5-Carboxylate Reductase 1: A Novel Target for Sensitizing Myeloma to Cytotoxic Agents By Inhibition of PRAS40-Mediated Protein Synthesis

Inge Oudaert, Hatice Satilmis, Philip Vlummens, Anke Maes, Elke De Bruyne, Karin Vanderkerken, Sarah-Maria Fendt, Kim De Veirman, Eline Menu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1574.
https://doi.org/10.1182/blood-2021-149156
Published: 2021
Journal Articles

Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo

Rong Fan, Hatice Satilmis, Niels Vandewalle, Elke De Bruyne, Eline Menu, Andrew D Chantry, Holly Evans, Marie Törngren, Helena Eriksson, Karine Breckpot, Ken Maes, Karin Vanderkerken, Kim De Veirman
Journal: Blood
Blood (2021) 138 (Supplement 1): 1594.
https://doi.org/10.1182/blood-2021-147744
Published: 2021